Brown Brothers Harriman & CO Johnson & Johnson Transaction History

Brown Brothers Harriman & CO

$12.7 Billion
Q2 2024

A detailed history of Brown Brothers Harriman & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 373,245 shares of JNJ stock, worth $62 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

373,245

Previous 381,602 2.19%

Holding current value

$62 Million

Previous $60.4 Million 9.63%

% of portfolio

0.43%

Previous 0.49%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$144.38 - $157.78 $1.21 Million - $1.32 Million	-8,357 Reduced 2.19%	373,245 $54.6 Million
Q1 2024 May 10, 2024	SELL	$155.22 - $162.74 $492,668 - $516,536	-3,174 Reduced 0.82%	381,602 $60.4 Million
Q4 2023 Feb 12, 2024	BUY	$145.6 - $158.88 $3.1 Million - $3.38 Million	21,265 Added 5.85%	384,776 $60.3 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $7.36 Million - $8.25 Million	-47,284 Reduced 11.51%	363,511 $56.6 Million
Q2 2023 Aug 07, 2023	BUY	$154.35 - $166.11 $4.95 Million - $5.33 Million	32,061 Added 8.47%	410,795 $68 Million
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $4.38 Million - $5.23 Million	29,003 Added 8.29%	378,734 $58.7 Million
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $10.7 Million - $12 Million	66,540 Added 23.5%	349,731 $61.8 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $1.58 Million - $1.76 Million	9,778 Added 3.58%	283,191 $46.3 Million
Q2 2022 Aug 11, 2022	BUY	$168.19 - $186.01 $395,919 - $437,867	2,354 Added 0.87%	273,413 $48.5 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $3.18 Million - $3.61 Million	-20,128 Reduced 6.91%	271,059 $48 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $2.84 Million - $3.15 Million	18,231 Added 6.68%	291,187 $49.8 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $5.59 Million - $6.21 Million	-34,609 Reduced 11.25%	272,956 $44.1 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $83,886 - $89,982	526 Added 0.17%	307,565 $50.7 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $1.9 Million - $2.12 Million	-12,427 Reduced 3.89%	307,039 $50.5 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $245,701 - $282,024	1,792 Added 0.56%	319,466 $50.3 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $802,131 - $878,984	-5,714 Reduced 1.77%	317,674 $47.3 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $1.54 Million - $1.86 Million	-11,981 Reduced 3.57%	323,388 $45.5 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $1.65 Million - $2.28 Million	-14,838 Reduced 4.24%	335,369 $44 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $1.18 Million - $1.35 Million	-9,239 Reduced 2.57%	350,207 $51.1 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $383,769 - $429,689	3,023 Added 0.85%	359,446 $46.5 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $1.09 Million - $1.19 Million	-8,283 Reduced 2.27%	356,423 $49.6 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $765,886 - $851,600	-6,092 Reduced 1.64%	364,706 $51 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $8.04 Million - $9.68 Million	65,473 Added 21.44%	370,798 $47.9 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $2.04 Million - $2.4 Million	16,799 Added 5.82%	305,325 $42.2 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $506,733 - $559,189	-4,244 Reduced 1.45%	288,526 $35 Million
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $1.23 Million - $1.46 Million	9,859 Added 3.48%	292,770 $37.5 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $3.95 Million - $4.32 Million	-30,111 Reduced 9.62%	282,911 $39.5 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $762,189 - $796,982	-5,887 Reduced 1.85%	313,022 $40.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	318,909	318,909 $42.2 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Johnson & Johnson Transaction History